Raymond Bergan

Professor

  • 3822 Citations
  • 36 h-Index
1977 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Raymond Bergan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Genistein Medicine & Life Sciences
Prostate Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Cell Movement Medicine & Life Sciences
Oligodeoxyribonucleotides Medicine & Life Sciences
Suramin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1977 2020

SPORE in Prostate Cancer

Bergan, R., Jindan, Y., Kaul, K. L., Catalona, W., Jovanovic, B., Abdulkadir, S. A. & Szmulewitz, R.

National Institutes of Health

8/18/157/31/20

Project: Research project

Research Personnel
Prostatic Neoplasms
Mentors
Research
Publications
Cell Movement
Neoplasm Metastasis
Prostatic Neoplasms
Phosphorylation
Neoplasms
Genistein
Cell Movement
Prostatic Neoplasms
HSP27 Heat-Shock Proteins
Prostate
Prostate
Genistein
Prostatic Neoplasms
Cell Survival
Growth

Research Output 1991 2019

  • 3822 Citations
  • 36 h-Index
  • 98 Article
  • 2 Review article
1 Citation (Scopus)

Genistein treatment duration effects biomarkers of cell motility in human prostate

Zhang, H., Gordon, R., Li, W., Yang, X., Pattanayak, A., Fowler, G., Zhang, L., Catalona, W. J., Ding, Y., Xu, L., Huang, X., Jovanovic, B., Kelly, D. L., Jiang, H. & Bergan, R., Mar 1 2019, In : PloS one. 14, 3, e0214078.

Research output: Contribution to journalArticle

Open Access
Genistein
genistein
Biomarkers
cell movement
Cell Movement

Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells

Li, Y., Guo, Y., Feng, Z., Bergan, R., Li, B., Qin, Y., Zhao, L., Zhang, Z. & Shi, M., Jan 1 2019, In : Nutrition and Cancer.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinases
Drug Resistance
Doxorubicin
Cell Line
HL-60 Cells

Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential (ESP) Charges

Mishra, R. K., Deibler, K. K., Clutter, M. R., Vagadia, P. P., O'Connor, M., Schiltz, G. E., Bergan, R. & Scheidt, K. A., Jan 1 2019, (Accepted/In press) In : Journal of Chemical Information and Modeling.

Research output: Contribution to journalArticle

Electrostatics
activity structure
Phosphotransferases
non-alignment
predictive model

Rapid fabrication of vascularized and innervated cell-laden bone models with biomimetic intrafibrillar collagen mineralization

Thrivikraman, G., Athirasala, A., Gordon, R., Zhang, L., Bergan, R., Keene, D. R., Jones, J. M., Xie, H., Chen, Z., Tao, J., Wingender, B., Gower, L., Ferracane, J. & Bertassoni, L., Dec 1 2019, In : Nature communications. 10, 1, 3520.

Research output: Contribution to journalArticle

Open Access
Biomimetics
biomimetics
collagens
bones
Bone
1 Citation (Scopus)

Synthesis and Biological Evaluation of 3-Arylindazoles as Selective MEK4 Inhibitors

Deibler, K. K., Schiltz, G. E., Clutter, M. R., Mishra, R. K., Vagadia, P. P., O'Connor, M., George, M. D., Gordon, R., Fowler, G., Bergan, R. & Scheidt, K. A., Jan 1 2019, In : ChemMedChem.

Research output: Contribution to journalArticle

MAP Kinase Kinase 4
Benzoic Acid
Molecular modeling
Oncology
p38 Mitogen-Activated Protein Kinases